No abstract available
Keywords:
Leqvio; Nexletol; Nexlizet; Praluent; Repatha; Zetia; adverse effects; alirocumab; bempedoic acid; dosage; efficacy; evolocumab; ezetimibe; inclisiran; safety; statins.
MeSH terms
-
Dicarboxylic Acids* / adverse effects
-
Dicarboxylic Acids* / therapeutic use
-
Fatty Acids* / administration & dosage
-
Fatty Acids* / adverse effects
-
Humans
Substances
-
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
-
Dicarboxylic Acids
-
Fatty Acids